Addex Therapeutics (NasdaqCM:ADXN) Q3 2025 Earnings Call December 04, 2025 10:00 AM ET Company ParticipantsMikhail Kalinichev - Head of Translational ScienceRam Selvaraju - Managing DirectorTim Dyer - CEOOperatorThank you for standing by. Welcome to the Addex Therapeutics third quarter 2025 financial results and corporate update conference call and webcast. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be the question-and-answer session. To ask a questi ...